---
schema_version: "secwatch.filing_event.v1"
accession: "0001626199-24-000063"
form_type: "8-K"
ticker: null
cik: "0001626199"
company_name: "ALPINE IMMUNE SCIENCES, INC."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:05:55.524232+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Vertex to acquire Alpine Immune for $65/share; Q1 net loss $17.9M

## Summary
- Vertex acquires Alpine for $65 per share in cash; transaction unanimously approved, expected to close in Q2 2024.
- Q1 net loss $17.9M ($0.28 per share) vs $13.3M loss in Q1 2023.
- Cash and investments $362.4M as of March 31, 2024; sufficient to fund operations into 2026.
- Collaboration revenue $7.0M, down from $9.4M; R&D expense up to $22.5M from $19.6M.

## SEC filing metadata
- accession: 0001626199-24-000063
- form_type: 8-K
- cik: 0001626199
- company_name: ALPINE IMMUNE SCIENCES, INC.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626199/000162619924000063/0001626199-24-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626199/000162619924000063/alpn-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001626199-24-000063
- JSON: https://secwatch.observer/filing/0001626199-24-000063.json
- Plain text: https://secwatch.observer/filing/0001626199-24-000063.txt

## Key facts
- Earnings Releases
  ALPINE IMMUNE SCIENCES, INC. reported financial results for first quarter ended March 31, 2024.
  - Period: first quarter ended March 31, 2024
  - Result: reported results
  source text: On May 9, 2024, Alpine Immune Sciences, Inc. issued a press release reporting its financial results for the three months ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626199/000162619924000063/0001626199-24-000063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.